Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized RegulationsOriginal Research Published on 2023-10-202024-09-05 Journal: Therapeutic innovation & regulatory science [Category] update2024, [키워드] Conditional COVID-19 EMA Emergency use Marketing authorizations Regulations USFDA [DOI] 10.1007/s43441-023-00574-6 PMC 바로가기 [Article Type] Original Research
Food Allergy Labeling Laws: International Guidelines for Residents and TravelersReview Published on 2023-05-092024-09-05 Journal: Clinical reviews in allergy & immunology [Category] update2024, [키워드] airlines anaphylaxis countries EMA epinephrine FDA food allergy Food allergy action plans Ingredients Labeling laws Traveling [DOI] 10.1007/s12016-023-08960-6 PMC 바로가기 [Article Type] Review
Making COVID-19 mRNA vaccines accessible: challenges resolvedArticle Published on 2022-09-012023-07-09 Journal: Expert review of vaccines [Category] COVID19(2023년), [키워드] COVID-19 developing countries EMA FDA LDCs LNP mRNA vaccine SARS-CoV2 TRIPS Vaccines WTO [DOI] 10.1080/14760584.2022.2089121
Evolution of Anti-SARS-CoV-2 Therapeutic AntibodiesArticle Published on 2022-08-282022-11-15 Journal: International Journal of Molecular Sciences [Category] SARS, 변종, 진단, [키워드] antibodies antibody approval authorization bamlanivimab bebtelovimab Casirivimab caused Characteristics cilgavimab claimed conserved COVID-19 COVID-19 pandemic Critical Diseases drug Efficacy EMA Emergency epitope etesevimab EUA European Evolution of SARS-CoV-2 FDA Features food HCDR3 help Imdevimab information Interaction Medicine Modification neutralization nine Prevent RBD regdanvimab regions residue SARS-CoV-2 somatic mutations Sotrovimab the receptor-binding domain therapeutic therapeutic antibodies Tixagevimab treat variants of concern viral infection VoC VOCs [DOI] 10.3390/ijms23179763 PMC 바로가기
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox OutbreakArticle Published on 2022-08-252022-11-15 Journal: Viruses [Category] Fulltext, 원숭이두창, 진단, 치료제, [키워드] animal antivirals approved benefit Canada clinical study COVID-19 development disease dosage drug drug combination drug resistance Efficacy EMA European Medicines Agency food forms Health Canada highlight infections injection Interaction literature literature review Monkeypox MOST non-human primate off-label orthopoxvirus outbreak parameters Patent patents. pharmacokinetic regulatory agency rule SIGA-246 technology tecovirimat TPOXX treat Treatment United State USA Viral diseases website [DOI] 10.3390/v14091870 PMC 바로가기
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humansResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] 임상, [키워드] Administered administration African age approach AstraZeneca AstraZeneca COVID-19 vaccine Blood ChAdOx1 nCoV-19 clinical development clinical trials conducted coronavirus disease country COVID-19 COVID-19 vaccine Denmark described Effectiveness Efficacy EMA Europe European European Medicines Agency groups Human humans immunogenicity data information initial lack limit MHRA observational study Occurrence positive Safety shown supported the vaccine thrombotic Thrombotic thrombocytopenia triggered UK Medicine union Vaccine WHO World Health Organization [DOI] 10.1016/j.therap.2022.07.003 [Article Type] Research article
[Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination][니르마트렐비르와 리토나비르(팍슬로비드)의 강력한 SARS-CoV-2 3CLpro 프로테아제 억제제 조합]Review Published on 2022-06-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] 3CL 3CLpro Administered adverse effects Antiviral antiviral drug antiviral drugs antiviral efficacy approved average conserved coronavirus Coronaviruses death duration of treatment effective Effectiveness EMA English FDA Final Hospitalization IMPROVE indican inhibitory activity media metabolism Modification Nirmatrelvir NSP11 Pandemia pandemic Patient Paxlovid PF-07321332 polyproteins pp1a pp1ab processing protease Protease inhibitor Proteases Proteins reducing risk Ritonavir SARS-CoV-1 SARS-CoV-2 sequence shown Spanish therapeutic target Treatment Viral variants [DOI] 10.37201/req/002.2022 PMC 바로가기 [Article Type] Review
Daily mindfulness training reduces negative impact of COVID-19 news exposure on affective well-beingRandomized Controlled Trial Published on 2022-06-012022-10-05 Journal: Psychological research [Category] 임상, [키워드] Affect affective Anxiety assessment assigned baseline boost buffer COVID-19 COVID-19 pandemic Daily Depression ecological EMA examined group highlight impacted increase in indicate measure mental health mitigate pandemic participant positive Protective questionnaire Randomly reduce reported utility [DOI] 10.1007/s00426-021-01550-1 PMC 바로가기 [Article Type] Randomized Controlled Trial
SARS-CoV-2 infection after vaccination in Italian health care workers: a case reportShort Communication Published on 2022-03-062022-10-30 Journal: National Academy Science Letters. National Academy of Sciences, India [Category] COVID-19, [키워드] A570D Analysis antibody approval B.1.1.7 Care carried Case report Complete COVID-19 COVID-19 vaccination D614G Diseases EMA FIVE genetic variants genotyping Health healthcare healthcare worker Healthcare workers hospital identify immunization Infection Italian Italy mild COVID-19 symptoms Mild symptom N501Y Nasopharyngeal swab National outbreak Patient performed physician positive Post-vaccinal infection Protein RNA extract SARS-CoV-2 SARS-COV-2 infection sequence source of infection spike Surveillance swabs tested vaccination Vaccine variant variants VoC [DOI] 10.1007/s40009-022-01106-w PMC 바로가기 [Article Type] Short Communication
Ecological momentary intervention to enhance emotion regulation in healthcare workers via smartphone: a randomized controlled trial protocolStudy Protocol Published on 2022-03-052022-10-27 Journal: BMC Psychiatry [Category] Coronavirus, MERS, SARS, [키워드] app arises assigned Burnout CBT cognitive composed control group COVID-19 pandemic DBT disseminate ecological Ecological momentary intervention Efficacy EMA EMI Emotion regulation emotional ENhance evaluate first RCT Follow-up groups Health professional healthcare healthcare worker help impacted IMPROVE include individual Intervention knowledge offer outcome participant post-intervention Primary outcome problems protocol psychological support Quality of life Randomized controlled trial Randomly RCT real time recruitment Regulation Resilience reveal secondary secondary outcome Self-efficacy Smartphone Stress supplementary material Therapies therapy Transdiagnostic Treatment [DOI] 10.1186/s12888-022-03800-x PMC 바로가기 [Article Type] Study Protocol